Deepak Cyril D’Souza

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

Deepak Cyril D’Souza, Edward Perry, Lisa Macdougall et al. · Neuropsychopharmacology · 2004 · 1K citations · Full text

Cannabis Use, Substance Abuse, Healthy Individuals +14

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

Deepak Cyril D’Souza, Walid Abi‐Saab, Steven Madonick et al. · Biological Psychiatry · 2005 · 604 citations

Cannabis Use, Delta-9-tetrahydrocannabinol Effects, Substance Abuse +14

Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia

Mark Slifstein, Elsmarieke van de Giessen, Jared X. Van Snellenberg et al. · JAMA Psychiatry · 2015 · 386 citations · Full text

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

John H. Krystal, Walid Abi‐Saab, Edward Perry et al. · Psychopharmacology · 2004 · 272 citations

Psychiatry, Brain Function, Medicine +11

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

Deepak Cyril D’Souza, Mohini Ranganathan, Gabriel Braley et al. · Neuropsychopharmacology · 2008 · 258 citations · Full text

Cannabis Use, Psychoactive Drug, Psychiatry +14